Here is why NERX is not worth any meaningful market Cap.
1. NERX on clinical hold 2. No meaningful PIII data for either STR or Pretarget. No meaningful PII data without a whole lot of baggage. 3. Piss poor track record. 4. Bad message to the street by buying a Contract Manufacturing facility that is losing money while cash is on short supply at NERX. 5. Points 1 and 2 again. 6. No large pharma interest 7. Use of niche radioisotopes 166Ho and 90Y. 8. Cheerleaders like you who can not understand the importance of doing a synergy arm with Rituxin. BFD if it doesn't synergize, but if it does it is low cost and low risk with huge upside. 9. Can not control clinical trials. 10. Talks more about animal data than human data ten years in the making. 11. NERX still doesn't get it (or know that you certainly do not get it) that PII trials can generate data that can be put into any kind of spin and it is all about finding an effective dose. PIII is about proving it.